Offered by: Nemours Children's
Location: Delaware Valley, Jacksonville, FL
Phase I Traditional 3+3 Trial of PO Sorafenib in Refractory or Recurrent Pediatric Solid Malignancies
View on Clinicaltrials.gov
To establish the safest doses of Topotecan and Sorafenib when given together to children whose tumors have not responded to treatment or whose tumors have come back despite treatment.
Age >3 years and ≤18 years of age at the time of study entry.
Trial Name: Phase I Traditional 3+3 Trial of PO Sorafenib in Refractory or Recurrent Pediatric Solid Malignancies
View on Clinicaltrials.gov
IRB#: 385771
(800) 354-5690 Email UsLearn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.